Literature DB >> 6324754

Characterization of the protein kinase activities of human platelet supernatant and particulate fractions.

S E Salama, R J Haslam.   

Abstract

After human platelets were lysed by freezing and thawing in the presence of EDTA, about 35% of the total cyclic AMP-dependent protein kinase activity was specifically associated with the particulate fraction. In contrast, Ca2+-activated phospholipid-dependent protein kinase was found exclusively in the soluble fraction. Photoaffinity labelling of the regulatory subunits of cyclic AMP-dependent protein kinase with 8-azido-cyclic [32P]AMP indicated that platelet lysate contained a 4-fold excess of 49 000-Da RI subunits over 55 000-Da RII subunits. The RI and RII subunits were found almost entirely in the particulate and soluble fractions respectively. Chromatography of the soluble fraction on DEAE-cellulose demonstrated a single peak of cyclic AMP-dependent activity with the elution characteristics and regulatory subunits characteristic of the type-II enzyme. A major enzyme peak containing Ca2+-activated phospholipid-dependent protein kinase was eluted before the type-II enzyme, but no type-I cyclic AMP-dependent activity was normally observed in the soluble fraction. The particulate cyclic AMP-dependent protein kinase and associated RI subunits were solubilized by buffers containing 0.1 or 0.5% (w/v) Triton X-100, but not by extraction with 0.5 M-NaCl, indicating that this enzyme is firmly membrane-bound, either as an integral membrane protein or via an anchor protein. DEAE-cellulose chromatography of the Triton X-100 extracts demonstrated the presence of both type-I cyclic AMP-dependent holoenzyme and free RI subunits. These results show that platelets contain three main protein kinase activities detectable with histone substrates, namely a membrane-bound type-I cyclic AMP-dependent enzyme, a soluble type-II cyclic AMP-dependent enzyme and Ca2+-activated phospholipid-dependent protein kinase, which was soluble in lysates containing EDTA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324754      PMCID: PMC1153340          DOI: 10.1042/bj2180285

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  On the question of translocation of heart cAMP-dependent protein kinase.

Authors:  S L Keely; J D Corbin; C R Park
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Comparison of adenosine 3':5'-monophosphate-dependent protein kinases from rabbit skeletal and bovine heart muscle.

Authors:  F Hofmann; J A Beavo; P J Bechtel; E G Krebs
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

3.  The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues.

Authors:  J D Corbin; S L Keely; C R Park
Journal:  J Biol Chem       Date:  1975-01-10       Impact factor: 5.157

4.  Thrombin-induced protein phosphorylation in human platelets.

Authors:  R M Lyons; N Stanford; P W Majerus
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

5.  The effect of ADP, calcium and some inhibitors of platelet aggregation on protein phosphokinases from human blood platelets.

Authors:  G A Bishop; M C Rozenberg
Journal:  Biochim Biophys Acta       Date:  1975-03-28

6.  Endogenous phosphorylation of platelet membrane proteins.

Authors:  M Steiner
Journal:  Arch Biochem Biophys       Date:  1975-11       Impact factor: 4.013

7.  Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine.

Authors:  R J Haslam; J A Lynham
Journal:  Life Sci II       Date:  1972-12-08

Review 8.  Role of cyclic AMP in platelet function.

Authors:  E W Salzman; H Weisenberger
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

9.  Purification and properties of a soluble cyclic AMP-dependent protein kinase from human platelets.

Authors:  H D Kaulen; R Gross
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-04

10.  Adenosine cyclic 3',5'-monophosphate-dependent protein kinase from human platelets.

Authors:  F M Booyse; J Marr; D C Yang; D Guiliani; M E Rafelson
Journal:  Biochim Biophys Acta       Date:  1976-01-23
View more
  4 in total

1.  Comparative studies on the energetics of platelet responses induced by different agonists.

Authors:  A J Verhoeven; M E Mommersteeg; J W Akkerman
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

2.  Platelet stimulation releases a cAMP-dependent protein kinase that specifically phosphorylates a plasma protein.

Authors:  B Korc-Grodzicki; M Tauber-Finkelstein; S Shaltiel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

3.  Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP.

Authors:  M Bushfield; A McNicol; D E MacIntyre
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

4.  Prostacyclin inhibits platelet aggregation induced by phorbol ester or Ca2+ ionophore at steps distal to activation of protein kinase C and Ca2+-dependent protein kinases.

Authors:  W Siess; E G Lapetina
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.